Trexquant Investment’s Novavax NVAX Stock Holding History

Trexquant Investment’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.35M	Buy	+461,742	New	+$4.14M	0.03%	817
2025 Q1	–	Sell	-150,085	Closed	-$1.21M	–	1775
2024 Q4	$1.21M	Sell	150,085 -516,572	-77%	-$4.98M	0.01%	1039
2024 Q3	$8.42M	Buy	+666,657	New	+$8.61M	0.11%	288
2022 Q3	–	Sell	-18,805	Closed	-$967K	–	1705
2022 Q2	$967K	Buy	+18,805	New	+$974K	0.04%	532
2016 Q2	–	Sell	-10,250	Closed	-$1.06M	–	1021
2016 Q1	$1.06M	Buy	+10,250	New	+$1.1M	0.12%	278
2015 Q4	–	Sell	-835	Closed	-$117K	–	1201
2015 Q3	$117K	Buy	835 +45	+6%	+$10.1K	0.01%	991
2015 Q2	$176K	Sell	790 -8,864	-92%	-$1.56M	0.02%	927
2015 Q1	$1.6M	Buy	+9,654	New	+$1.57M	0.16%	185

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Trexquant Investment's NVAX Position: Q2 2026 in Review

Trexquant Investment opened a new position in Novavax (NVAX) in Q2 2026: 461,742 shares worth $4.35M. The stake represents 0.03% of the portfolio and ranks #817 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in NVAX as recently as Q4 2024.

Trexquant Investment first reported a position in NVAX in Q1 2015 and has held it in 8 quarters since. The position peaked at $8.42M in Q3 2024. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Trexquant Investment held 461,742 shares of Novavax worth $4.35M as of Q2 2026.
Novavax was a new Trexquant Investment position in Q2 2026.
Novavax made up 0.03% of Trexquant Investment's portfolio in Q2 2026, its #817 holding.
Trexquant Investment first reported a position in Novavax in Q1 2015 and has held it in 8 quarters since.
Trexquant Investment's Novavax position peaked at $8.42M in Q3 2024.
268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.